IP Verse

Recombinant Co-Expression Of Vitamin K Epoxide Reductase Subunit 1 To Improve Vitamin K Dependant Protein Expression

PatentPatent Analysis

EP2295547

BAXALTA
Application Number
EP10010933A
Filing Date
Jan 27, 2006
Status
Revoked
Jun 28, 2019
Grant Date
Sep 20, 2017
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3064508B2
EP3521422B1
EP3277718B1

Bibliography

The patent EP2295547B1 was granted to Baxalta on Sep 20, 2017 following the initial filing on Jan 27, 2006 under the application number EP10010933A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

APTEVO BIOTHERAPEUTICSJun 18, 2018ADMISSIBLE

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents